Drug Shortage Report for ROCURONIUM BROMIDE INJECTION

Last updated on 2024-09-30 History
Report ID 236607
Drug Identification Number 02517744
Brand name ROCURONIUM BROMIDE INJECTION
Common or Proper name ROCURONIUM BROMIDE INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ROCURONIUM BROMIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5mL
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-09-04
Estimated end date 2024-09-25
Actual end date 2024-09-27
Shortage status Resolved
Updated date 2024-09-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-09-04 English Compare
v2 2024-09-04 French Compare
v3 2024-09-05 English Compare
v4 2024-09-23 English Compare
v5 2024-09-23 French Compare
v6 2024-09-30 English Compare
v7 2024-09-30 French Compare

Showing 1 to 7 of 7